ATRX Adhera Therapeutics Inc

Price (delayed)

$0.08

Market cap

$930,457

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.49

Enterprise value

$7.25M

Sector: Healthcare
Industry: Biotechnology

Highlights

The net income has soared by 69% YoY and by 49% from the previous quarter
Adhera Therapeutics's EPS has surged by 60% YoY and by 40% QoQ
The gross profit has dropped by 100% since the previous quarter but it has surged by 100% year-on-year
ATRX's revenue has dropped by 100% since the previous quarter and by 100% year-on-year
ATRX's equity is down by 49% year-on-year and by 5% since the previous quarter

Key stats

What are the main financial stats of ATRX
Market
Shares outstanding
11.63M
Market cap
$930,457
Enterprise value
$7.25M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$1.99M
EBITDA
-$1.99M
Free cash flow
-$588,000
Per share
EPS
-$0.49
Free cash flow per share
-$0.05
Book value per share
-$1.36
Revenue per share
$0
TBVPS
$0
Balance sheet
Total assets
$1,000
Total liabilities
$14.77M
Debt
$6.32M
Equity
-$14.77M
Working capital
-$14.77M
Liquidity
Debt to equity
-0.43
Current ratio
0
Quick ratio
0
Net debt/EBITDA
-3.17
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-4,065.9%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRX stock price

How has the Adhera Therapeutics stock price performed over time
Intraday
0%
1 week
0%
1 month
-11.11%
1 year
100%
YTD
100%
QTD
-11.11%

Financial performance

How have Adhera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$2.04M
Net income
-$3.77M
Gross margin
N/A
Net margin
N/A
The gross profit has dropped by 100% since the previous quarter but it has surged by 100% year-on-year
ATRX's revenue has dropped by 100% since the previous quarter and by 100% year-on-year
Adhera Therapeutics's operating income has surged by 82% YoY and by 64% QoQ
The net income has soared by 69% YoY and by 49% from the previous quarter

Growth

What is Adhera Therapeutics's growth rate over time

Valuation

What is Adhera Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Adhera Therapeutics's EPS has surged by 60% YoY and by 40% QoQ
ATRX's equity is down by 49% year-on-year and by 5% since the previous quarter
ATRX's revenue has dropped by 100% since the previous quarter and by 100% year-on-year

Efficiency

How efficient is Adhera Therapeutics business performance
The ROA has contracted by 8% from the previous quarter

Dividends

What is ATRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRX.

Financial health

How did Adhera Therapeutics financials performed over time
ATRX's total assets is 100% smaller than its total liabilities
The company's current ratio has shrunk by 100% YoY
ATRX's total assets has dropped by 100% year-on-year and by 98% since the previous quarter
The debt is 143% greater than the equity
ATRX's equity is down by 49% year-on-year and by 5% since the previous quarter
Adhera Therapeutics's debt to equity has increased by 20% YoY and by 4.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.